Concepedia

Author

Andrew J. Sleight

Roche (Switzerland)

Also Known As

A J Sleight, A. J. SLEIGHT, A. J. Sleight, A. Sleight, A.J Sleight, A.J. SLEIGHT, A.J. Sleight, ANDREW J. SLEIGHT, Andrew J Sleight, Andrew J. Sleight

80

Publications

4.3K

Citations

35

H-Index

64

Concepts

All Affiliations

Roche (Switzerland)Queen's Medical CentreUniversity of NottinghamStanford University
AJ

About

Andrew J. Sleight is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

31

2.1K

2

Social Sciences

11

11

882

3

Natural Sciences

6

6

155

4

Health Sciences

1

1

77

5

Anesthesia

1

1

333

Andrew J. Sleight

×

46

Publications

3.8K

Citations

33

H-Index

YearCitations

5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential

Joel R. Martin, Michael Bös, F. Jenck,

Journal of Pharmacology and Experimental Therapeutics

1998

334

Prolonged sedation due to accumulation of conjugated metabolites of midazolam

Tilman Bauer, R Ritz, C. Haberthür,

The Lancet

1995

333

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

Cem Gabay, Bruno Fautrel, Jürgen Rech,

Annals of the Rheumatic Diseases

2018

284

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze

Marie L. Woolley, Jane Bentley, Andrew J. Sleight,

Neuropharmacology

2001

200

5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation—an effect sensitive to NMDA receptor antagonism

Madeleine V. King, Andrew J. Sleight, Marie L. Woolley,

Neuropharmacology

2004

192

Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT<sub>6</sub> receptors

Andrew J. Sleight, Frank Boess, Michael Bös,

British Journal of Pharmacology

1998

179

Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides.

Anne Bourson, Edilio Borroni, Rachel H. Austin,

Journal of Pharmacology and Experimental Therapeutics

1995

179

Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.

Andrew J. Sleight, C. CAROLO, Nadine Petit,

Molecular Pharmacology

1995

154

Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro�04-6790

Marie L. Woolley, C.A. Marsden, Andrew J. Sleight,

Psychopharmacology

2003

123

Characterization of (<i>R</i>,<i>S</i>)‐5,7‐di‐<i>tert</i>‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3<i>H</i>‐benzofuran‐2‐one as a positive allosteric modulator of GABA<sub>B</sub>receptors

Pari Malherbe, Raffaello Masciadri, Roger D. Norcross,

British Journal of Pharmacology

2008

102

Page 1